Split27 Feb 2026, 06:29 pm
Titan Biotech Ltd Announces 5:1 Equity Share Split
AI Summary
Titan Biotech Ltd has announced a 5:1 sub-division/split of its equity shares. The face value of the shares has been reduced from Rs. 10/- to Rs. 2/- each. The sub-divided shares have been credited under new ISIN: INE150C01029 by National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). The confirmation letters issued by NSDL and CDSL are enclosed for reference. The corporate action was executed by Beetal Financial & Computer Services Pvt. Ltd, and the shares were credited/debited to the accounts in the NSDL system.
Key Highlights
- Titan Biotech Ltd announces a 5:1 sub-division/split of its equity shares.
- The face value of the shares has been reduced from Rs. 10/- to Rs. 2/- each.
- The sub-divided shares have been credited under new ISIN: INE150C01029 by NSDL and CDSL.
- The corporate action was executed by Beetal Financial & Computer Services Pvt. Ltd.
- The shares were credited/debited to the accounts in the NSDL system.